Veradigm (Veradigm) EBIT per Share : $1.01 (TTM As of Sep. 2022)

View and export this data going back to 1999. Start your Free Trial

What is Veradigm EBIT per Share?

Veradigm's EBIT per Share for the three months ended in Sep. 2022 was $0.20. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 was $1.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Veradigm's EBIT per Share or its related term are showing as below:

MDRX's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 7.85
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Veradigm's EBIT for the three months ended in Sep. 2022 was $26 Mil.

Veradigm EBIT per Share Historical Data

The historical data trend for Veradigm's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veradigm EBIT per Share Chart

Veradigm Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

EBIT per Share

Get a 7-Day Free Trial

-0.84

-0.06

-1.44

-0.72

1.26

Veradigm Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EBIT per Share	Get a 7-Day Free Trial															0.24	0.80	0.05	-0.03	0.20

Veradigm EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Veradigm's EBIT per Share for the fiscal year that ended in Dec. 2021 is calculated as

	EBIT per Share		(A: Dec. 2021 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	174.992	/	138.658
=	1.26

Veradigm's EBIT per Share for the quarter that ended in Sep. 2022 is calculated as

	EBIT per Share		(Q: Sep. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	26.039	/	128.871
=	0.20

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.01

Veradigm (OTCPK:MDRX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Veradigm EBIT per Share Related Terms

Thank you for viewing the detailed overview of Veradigm's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Veradigm (Veradigm) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veradigm Inc (OTCPK:MDRX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654

Website

https://www.veradigm.com

Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

Executives

Shih Yin Ho	director	222 MERCHANDISE MART, SUITE 2024, CHICAGO IL 60654
Susan Rodriguez	director	C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555
Richard J. Poulton	officer: CFO	3646 WESTFIELD LANE, GLENVIEW IL 60026
Tejal Vakharia	officer: SVP Gerneral Counsel	222 MERCHANDISE MART PLZ, SUITE 2024, CHICAGO IL 60654
David B Stevens	director	1 IMATION WAY, OAKDALE MN 55128
Leah Jones	officer: Chief Financial Officer	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Paul Black	director	400 WOOD ROAD, BRAINTREE MA 02184
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Thomas Langan	officer: President and CCO	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Lisa Hammond	officer: SVP & Chief HR Officer	305 CHURCH AT NORTH HILLS STREET, RALEIGH NC 27609
Greg Garrison	director	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Lisa Khorey	officer: Chief Client Delivery Officer	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Michael Klayko	director
Carol J Zierhoffer	director	100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Brian Farley	officer: SVP Gerneral Counsel & Corpora	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654